D-0142-2017 Class III Terminated
FDA drug recall D-0142-2017 was initiated by GSK Consumer Healthcare on Oct 18, 2016 and is designated Class III. Reason for recall: Labeling Not Elsewhere Classified: front labels have the incorrect NDC or 0145-1506-01 instead of the correct NDC of 0145-1506-05 and some back labels have the incorrect indication stating "use for… The recall status is terminated (terminated Nov 8, 2018). Affected quantity: 462,732 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 23, 2016
- Initiation Date
- Oct 18, 2016
- Termination Date
- Nov 8, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 462,732 bottles
Product description
Zeasorb AF (miconazole nitrate), 2%, cures most athlete's foot, Net wt. 2.5 OZ (71 g), Manufactured for: Steifel Laboratories, Inc., Research Triangle Park, NC 27709, UPC 0 73462 15065 1; NDC 0145-1506-01
Reason for recall
Labeling Not Elsewhere Classified: front labels have the incorrect NDC or 0145-1506-01 instead of the correct NDC of 0145-1506-05 and some back labels have the incorrect indication stating "use for the cure of most jock itch" rather than "use for the cure of most athlete's foot".
Distribution pattern
Nationwide in the USA
Code information
Lot #: 5M02ST*, 5M03ST*, 5M04ST*, Exp 10/17; 5P01ST, 5P01STA, 5P02ST, 5P03ST, 5P04ST, 5P05ST, Exp 11/17; 6C03ST, 6C04ST, 6C05ST, 6C06ST, 6C07ST, Exp 02/18 *Lots 5M02ST, 5M03ST, and 5M04ST contain the NDC code error only on front label, back label is correct.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0142-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026